LifeMine Therapeutics
Series ELifeMine Therapeutics is a privately held company based in United States, founded in 2016. The latest disclosed round is Series E ($188m), dated Aug 06, 2026. Institutional investors on record include Google Ventures.
United States · EST 2016
What is LifeMine Therapeutics?
LifeMine Therapeutics is a privately held company based in United States, founded in 2016. The latest disclosed round is Series E ($188m), dated Aug 06, 2026. Institutional investors on record include Google Ventures. Developer of novel drugs from fungi via genome mining and recombinant overexpression. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
Which funds backed LifeMine Therapeutics?
Who invested in LifeMine Therapeutics?
Funds on the dated round table. Open a name to read the fund card.
| Investor | Round | Amount | Date |
|---|---|---|---|
| Google Ventures | Series E | $188m | Aug 06, 2026 |
What do founders ask about LifeMine Therapeutics?
What is LifeMine Therapeutics?
LifeMine Therapeutics is a privately held company based in United States, founded in 2016. The latest disclosed round is Series E ($188m), dated Aug 06, 2026. Institutional investors on record include Google Ventures. Developer of novel drugs from fungi via genome mining and recombinant overexpression. CrackTheDeck lists dated rounds and linked fund profiles so founders can see who is already on the cap table before a pitch. Round sizes are shown only when disclosed. Empty fields mean the figure was not in those records. Open a fund name to read that firm's thesis, reported AUM, and recent dated deals. This page is compiled from financings linked to catalog funds. It is not a complete cap table. Founders use this card to check the latest disclosed round, amount, and syndicate before a meeting.
What was LifeMine Therapeutics's last funding round?
LifeMine Therapeutics's latest disclosed round is Series E at $188m (Aug 06, 2026).
Who invested in LifeMine Therapeutics?
LifeMine Therapeutics has 1 institutional investors on this page, including Google Ventures.
How does CrackTheDeck cover LifeMine Therapeutics?
This startup card lists dated rounds and linked fund profiles so founders can see who is already in the cap table before a pitch.
How is this page compiled?
Round, amount, and investor names on the LifeMine Therapeutics card come from dated financings linked to fund profiles in CrackTheDeck. Empty fields mean the figure was not in those records. Updated Aug 2026.